<DOC>
	<DOC>NCT00403715</DOC>
	<brief_summary>The purpose of this trial is to compare the effectiveness and safety of INS365 Ophthalmic Solution with Placebo when applied topically in subjects with dry eye disease.</brief_summary>
	<brief_title>Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>best corrected visual acuity in both eyes of at least +0.7 sixmonth documented history of dry eye disease at least mild severity in 2 of the 4 dry eye symptoms unanesthetized Schirmer score of less than or equal to 7mm corneal fluorescein staining of greater than or equal to 4 (out of 15) nasally stimulated Schirmer score of less than 3mm in subjects with an initial Schirmer score of 0mm ongoing contact lens wear current topical ophthalmic medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>